课题基金 / 基金详情

Northwestern University Allergy Immunology Research Program (NUAIR)

Northwestern University Allergy Immunology Research Program (NUAIR)
西北大学过敏免疫学研究计划(NUAIR)
批准号:
8665869
负责人:
Robert P Schleimer
金额:
$18.75万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-15 至 2015-08-14

项目摘要

项目成果

Robert P Schleimer的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):西北大学过敏-免疫学研究(NUAIR)项目的总体目标是培训博士后科学家进行翻译研究,在这里定义为疾病机制研究,包括对人体受试者或人体样本的调查。NUAIR计划建立在我们的过敏-免疫学奖学金的基础上,该奖学金在临床和学术培训方面有着悠久的卓越历史,而且自2004年以来,包括8名基础研究人员在内的教职员工人数最近翻了一番。我们与其他部门和部门的资深研究人员一起,在NUAIR计划中为翻译研究创造了一个丰富的环境,在这个环境中,临床和基础研究人员,包括教员和实习生,在每周的研究和教学活动中进行合作和互动。这些合作导致了几种过敏性疾病的多学科转化性研究计划,并得到了设备齐全的实验室和大量研究核心和设施的支持。根据NUAIR计划,最终稳定状态为每年3名医学博士和/或博士研究生实习生将开始为期2年的研究培训。每名学员将与一名临床研究导师和一名基础研究导师合作,研究过敏和免疫疾病的致病机制,包括对人体受试者或其样本的研究。除了结构良好的研究培训和教学活动外,根据里程碑对学员的表现进行强有力的指导和密切监测,将确保培训过程中取得适当进展。我们的留任计划包括为在两年的研究培训后留在我们部门的初级教员提供支持,同时寻求外部资金支持。我们还有激励医学生和住院医生从事过敏免疫学职业的计划。综上所述,我们快速扩展和全面的过敏免疫学研究环境将为高素质的医学博士和博士后学员提供最先进的研究培训。这些受训人员将在过敏免疫学领域开展合作的转化性研究,开启研究生涯,这将有助于缓解国家对该领域学术领袖的迫切需求。 相关性:西北大学过敏-免疫学研究(NUAIR)项目将培训医生和基础研究人员进行翻译研究,以提高我们对哮喘、过敏性疾病和免疫性疾病的机制的了解。这一新知识可能会为未来开发新的治疗方法、诊断测试和预防方法揭示新的目标。
英文摘要
DESCRIPTION (provided by applicant): The overall aim of the Northwestern University Allergy-Immunology Research (NUAIR) Program is to train postdoctoral scientists in translational research, here defined as research of disease mechanisms that includes investigations in human subjects or human samples. The NUAIR Program builds on our Allergy- Immunology Fellowship, which has a long history of excellence in clinical and academic training, and on the recent doubling of faculty members including 8 basic researchers since 2004. Together with established investigators from other Divisions and Departments, we have created a rich environment for translational research in the NUAIR program in which clinical and basic researchers, both faculty and trainees, collaborate and interact in weekly research and didactic activities. These collaborations have led to multidisciplinary translational research programs in several allergic diseases supported by well equipped laboratories and a large number of research cores and facilities. Under the NUAIR Program, an eventual steady state of 3 MD and/or PhD postgraduate trainees per year will start 2 years of research training. Each trainee will work together with a clinical research mentor and a basic research mentor to study pathogenic mechanisms of allergic and immunological diseases, including studies of human subjects or their samples. In addition to well structured research training and didactic activities, strong mentoring and close monitoring of trainees' performances based on milestones will ensure proper progress during training. Our retention plan includes support for trainees who remain in our Division as junior faculty members after 2 years of research training, while they seek external funding support. We also have programs to inspire medical students and residents to pursue careers in Allergy-Immunology. Taken together, our rapidly expanding and comprehensive Allergy-Immunology research environment will allow state-of-the-art research training to highly qualified MD and PhD postdoctoral trainees. These trainees will conduct collaborative translational research in Allergy-Immunology, initiating research careers that will help attenuate a severe national need for academic leaders in this field. RELEVANCE: The Northwestern University Allergy-Immunology Research (NUAIR) Program will train physicians and basic researchers on translational research to advance our knowledge of mechanisms of asthma, allergic conditions and immunological diseases. This new knowledge will likely reveal novel targets for future development of new treatments, diagnostic tests and preventive approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
Administrative Core
Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2)
  • 批准号:
    10225446
  • 项目类别:
  • 资助金额:
    $185.28万
  • 财政年份:
    2019
  • 负责人:
    Robert P Schleimer
  • 依托单位:
国内基金
海外基金
Cellular & Molecular Immunology
  • 批准号:
    30824806
  • 项目类别:
    专项基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2008
  • 负责人:
    魏海明
  • 依托单位: